Print Page | Contact Us | Sign In | Join FSN
Chronic Kidney Disease Clinical Trials
Chronic Kidney Disease

Name or Title of Research Study 

FLOW - Effect of semaglutide versus placebo on the progression of renal impairment in subjects with T2DM and CKD

Enrollment Criteria: Male or female, 18+ years of age and has type 2 diabetes mellitus (T2DM) and pre-existing chronic kidney disease (CKD) with an estimated glomerular filtration rate (eGFR) between 25 and 75 mL/min/1.73m2 inclusive.

Treatment: Semaglutide v. Placebo

Institution: UF Nephrology

Contact for Enrollment
Sherry Brown, BSN, RN, Clinical Trials Manager
sherry.brown@medicine.ufl.edu | 352-273-5661


 Chronic Kidney Disease

Name or Title of Research Study

Randomized parallel group double-blind placebo-controlled clinical trial of EMPAgliflozin once daily in patients with chronic KIDNEY disease

Enrollment Criteria: Male or female, 18+ years of age and has type 2 diabetes mellitus (T2DM) and pre-existing chronic kidney disease (CKD) with an estimated glomerular filtration rate (eGFR) between 20 and 90 mL/min/1.73m2 

Treatment: Empagliflozin v. Placebo

Institution: UF Nephrology

Contact for Enrollment
Sherry Brown, BSN, RN, Clinical Trials Manager
sherry.brown@medicine.ufl.edu | 352-273-5661


FLORIDA SOCIETY OF NEPHROLOGY
1215 E. Robinson Street, Orlando, FL 32801
Phone: 813-909-0450  |  Fax: 813-949-8994